HOME >> BIOLOGY >> NEWS
Hormone therapy does not improve quality of life for women

A postmenopausal hormone therapy trial conducted in Estonia indicates that hormone therapy does not improve women's quality of life. The group receiving hormones and the comparison group showed no differences in general quality of life. Only those women that experienced hot flashes and night-time sweating reported beneficial effects. These results were obtained from the Estonian Postmenopausal Hormone Therapy trial (EPHT) funded by the Academy of Finland and conducted under the leadership of Research Professor Elina Hemminki from the National Research and Development Centre for Welfare and Health (Stakes).

The trial examined the effects of hormone therapy on utilisation of health care services, onset of illnesses, and well-being. In 19992001, 1,823 postmenopausal women aged 50 to 64 were recruited in the Tallinn and Tartu regions. The women took the research medication for 2 to 5 years. Estonia was selected for the trial because hormone therapy is already established in Finland and physicians have a very positive attitude towards its use. Hormone therapy is still rare in Estonia.

Hormone therapy led to an increased number of health care visits and increased treatment costs. In comparison to the control group, more lower abdominal ultrasounds and electrocardiograms were performed on the group receiving hormone therapy, but there were no differences in the number of gynaecological or breast surgeries, bone density measurement or mammography.

The women receiving hormone therapy showed slightly more cardiovascular disease, cerebral circulatory disease and cancer in comparison to the women who did not take hormones. However, these differences were not statistically significant. The hormone recipients had less fractures and less hot flashes and night-time sweating than the comparison group, but they also had more flow. There were no differences in depression, sleep disorders, fatigue, dizziness or bloating.

The EPHT trial is the
'"/>

Contact: Niko Rinta
niko.rinta@aka.fi
Academy of Finland
6-Nov-2006


Page: 1 2

Related biology news :

1. Hormone that signals fullness also curbs fast food consumption and tendency to binge eat
2. Hormone resistance of pituitary tumors and Cushing disease explained
3. Hormones role in insects could give insight for cancer treatment, malnutrition
4. Hormones may affect how brain listens, Emory study finds
5. Hormone might cause dangerous pregnancy complication
6. Hormones and growth: The control of body size and developmental growth rate in fruit flies
7. Hormone therapys effect on breast density is not the same for all women, Group Health study finds
8. Testosterone replacement therapy: How safe for aging men?
9. Progesterone therapy and preterm birth: More evidence helps identify women who can benefit
10. Aggressive therapy best for certain AML patients
11. Under magnetic force, nanoparticles may deliver gene therapy

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/5/2020)... , ... June 04, 2020 , ... Greffex, a pioneering ... its Board of Directors. , “Neil understands the need for a global perspective to ... and CEO of Greffex. Mr. Bush will serve as an independent, director of the ...
(Date:5/28/2020)... ... May 27, 2020 , ... CrucialTrak, a global designer and manufacturer of biometric ... Group (CEG) to market and sell its complete line of biometric readers and ... infrastructure optimization solutions . , Brett Mason, CrucialTrak’s Director of Channel Sales ...
(Date:5/28/2020)... Texas (PRWEB) , ... May 28, 2020 , ... ... announced today that interim results from their 1801 Phase 1/2 study (NCT03678883, EudraCT ... (ASCO) Annual Meeting which will take place virtually on May 29th, 2020. Dr. ...
Breaking Biology News(10 mins):
(Date:7/10/2020)... ... July 09, 2020 , ... ... that Massachusetts Institute of Technology (MIT) has expanded the company’s exclusive license ... to move into the point-of-care diagnostic market, focusing initially on the SARS-CoV-2 ...
(Date:7/1/2020)... ... June 29, 2020 , ... MedShift , a leading ... despite many obstacles created as a result of COVID-19. As a provider at ... medical practices and medical manufacturers by expanding access to device offerings, technology services, ...
(Date:6/28/2020)... ... June 25, 2020 , ... ... for treating cancer, today announced the company has entered a license agreement with ... agreement provides Lumeda globally exclusive rights to Roswell Park intellectual property surrounding a ...
(Date:6/23/2020)... ... June 22, 2020 , ... Dracen ... will be presented June 22-24 during the American Association for Cancer Research Virtual ... other profiles the potent, consistent single agent activity in KEAP1 mutant tumor models ...
Breaking Biology Technology:
Cached News: